Fate Therapeutics (NASDAQ:FATE) Shares Gap Down to $6.76

Shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $6.76, but opened at $6.38. Fate Therapeutics shares last traded at $6.37, with a volume of 169,990 shares trading hands. Analysts Set New Price Targets FATE has been the topic […]

Related Keywords

United States ,America , ,Pricet Rowe Associates Inc ,Fate Therapeutics Inc ,Barclays ,Blackrock Inc ,Vanguard Group Inc ,Nasdaq ,Fate Therapeutics ,Get Free Report ,Therapeutics Stock Down ,Street Corp ,Capital World Investors ,World Investors ,Fate Therapeutics Daily ,Nasdaq Fate ,Fate ,Medical ,Stocks ,Technicals ,